Drugs
Trace registered interventions to the trials and evidence behind them.
(Z)-endoxifen
Registry intervention verified
0.5 mL dose of PCV20
Registry intervention verified
0.5 mL of the High-PFS dose VAX-31
Registry intervention verified
0.5 mL of the high dose VAX-31
Registry intervention verified
0.5 mL of the low dose VAX-31
Registry intervention verified
0.5 mL of the mid dose VAX-31
Registry intervention verified
0.5 mg epinephrine
Registry intervention verified
0.5 mg ranibizumab
Registry intervention verified
0.5 ml dose of 1.1 mcg VAX-24
Registry intervention verified
0.5 ml dose of 2.2 mcg VAX-24
Registry intervention verified
0.5 ml dose of 2.2/4.4 mcg VAX-24
Registry intervention verified
0.5 ml dose of PCV20
Registry intervention verified
0.5mg elsunersen
Registry intervention verified
1 mg epinephrine
Registry intervention verified
1.0mg/kg/day PRAX-562
Registry intervention verified
1.5mg/kg/day PRAX-562
Registry intervention verified
100 mg PRAX-944
Registry intervention verified
100 mg/m2 aldoxorubicin
Registry intervention verified
100 μg KIO-301
Registry intervention verified
131I-apamistamab
Registry intervention verified
150 mg/m2 aldoxorubicin
Registry intervention verified
1h Incubation Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)
Research association · unverified
1h Incubation Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)
Research association · unverified
1mg elsunersen
Registry intervention verified
2.0 aflibercept
Registry intervention verified
2.0 mg OPT-302
Registry intervention verified
20 mg/day vormatrogine for 12 weeks
Registry intervention verified
200 mg pembrolizumab
Registry intervention verified
200-1600 µg of MBX 2109 once-weekly by subcutaneous injection
Registry intervention verified
20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks
Registry intervention verified